NASDAQ · Biotechnology

DCOY (DCOY) Stock

$3.92 -2.73% NASDAQ: DCOY Healthcare

Valuation

MetricValue
Price$3.92
Market Cap$2.09M
P/E Ratio0.06
P/B Ratio0.84
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$415.80
52-Week Low$3.74
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-661.73%
ROA-54.13%
ROCE-216.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio2.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-13.0M$-32.0M$-13.0M$-6.0M$-13.0M
Net Profit$-13.0M$-32.0M$-13.0M$-6.0M$-13.0M
EPS$-926.01$-1785.33$-461.04$-86.92$-25.99
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$41.0M$15.0M$7.0M$3.0M$11.0M
Total Liabilities$2.0M$4.0M$1.0M$2.0M$5.0M
Cash$29.0M$12.0M$6.0M$2.0M$11.0M
Borrowings$0$0$0$0$0

Latest News

Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors PR Newswire · Jul 15, 2026 Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale MT Newswires · Jul 10, 2026 Top Premarket Decliners MT Newswires · Jun 30, 2026 Top Midday Gainers MT Newswires · Jun 29, 2026 DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally? Stocktwits · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-10.0M$-18.0M$-13.0M$-5.0M$-5.0M
Investing Cash Flow$0$-3.0M$0$0$1.0M
Financing Cash Flow$1.0M$0$0$0$12.0M
Net Cash Flow$18.0M$-17.0M$-6.0M$-3.0M$8.0M
Free Cash Flow$-10.0M$-19.0M$-13.0M$-5.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA0.99
FCF Yield-201.22%
Quick Ratio1.84
Interest Coverage—
Return 1Y-94.94%
Return 3Y-99.61%
Return 5Y-99.98%

Ownership

Insiders Held0.28%
Institutions Held5.76%
Institutions Float Held5.77%
Institutional HolderSharesReport Date
Tower Research Capital LLC (TRC)1,0212026-03-31
UBS Group AG5462026-03-31
Advisory Services Network, LLC412026-03-31
Morgan Stanley12026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About DCOY

DCOY is led by CEO Frederick E. Pierce, employs 2 people, headquartered in US, publicly traded since 2015.

DCOY stock trades at $3.92 with a market capitalization of $2.09M. The stock is valued at a price-to-earnings (P/E) ratio of 0.06, price-to-book of 0.84, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.74 and $415.80, and currently trades 99.1% below its 52-week high.

On profitability, DCOY generates a return on equity (ROE) of -661.73%, return on capital employed of -216.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides